Perbedaan UBC Medical Indonesia Tbk. dan Kian Santang Muliatama Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Kian Santang Muliatama Tbk. diperdagangkan di Rp214 (kapitalisasi pasar 312,28 M, volume 24 jam 7,8 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Kian Santang Muliatama Tbk. lebih aktif diperdagangkan (7,8 jt vs 3,48 jt). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | RGAS | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 312,28 M |
Volume | 3,48 jt | 7,8 jt |
Lot | 34,82 rb | 77,95 rb |
Perputaran | 522,79 jt | 1,64 M |
Harga Rata-rata | 150,13 | 210,89 |
Nilai Transaksi | 522,79 jt | 1,64 M |
Harga Ekuilibrium Indikatif | 148 | 214 |
Volume Ekuilibrium Indikatif | 350 | 1,33 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Selengkapnya di halaman RGAS →